13F filer · CIK 1667082
Biomark Capital Management Co. LLC
GREENWICH, CT · filing since Q4 2015 · last filing Oct 24, 2018
Reported value
$8.9M
+$2.4M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%
Biggest buys vs Q2 2018
No new or increased positions this quarter.
Biggest sells vs Q2 2018
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2018
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ADMA BIOLOGICS, INC.COM | 1,433,304 | $8.9M | 99.96% |
| 2 | MABVAX THERAPEUTICS HOLDINGS, INC.COM PAR | 8,903 | $4.0K | 0.04% |